Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension

Metabolism: Clinical and Experimental
A Haenni, H Lithell

Abstract

In a randomized double-blind crossover study in 42 patients with essential hypertension, the metabolic effects of a beta-adrenergic blocker with a pronounced beta 2-agonistic effect, dilevalol 400 mg x 1, were compared with those of metoprolol succinate 200 mg x 1. The effects of glucose metabolism were evaluated by the hyperinsulinemic euglycemic clamp technique and an intravenous glucose tolerance test (IVGTT). Insulin-mediated glucose disposal (M) and the insulin sensitivity index (M/I) increased by 19% (P = .011) and 10% (P = .27), respectively, during dilevalol treatment, but decreased by 10% (P = .15) and 22% (P = .0025), respectively, during metoprolol treatment, giving rise to significant differences between the two treatment regimens. Compared with dilevalol-treated patients, those treated with metoprolol showed increased plasma insulin values at the end of the IVGTT, but there was no difference in plasma glucose concentrations or glucose tolerance. Hemoglobin A1c (HbA1c) levels increased by 5.4% (P = .04) in the metoprolol group. Serum cholesterol, total serum and very-low-density lipoprotein (VLDL) triglycerides, and serum urate levels decreased significantly (by 6%, 22%, 29%, and 14%, respectively) during dilevalol ...Continue Reading

References

Oct 1, 1976·Metabolism: Clinical and Experimental·N TanakaT Kanehisa
Apr 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·P A WatkinsM D Lane
Aug 1, 1992·Journal of Cardiovascular Pharmacology·R van HoofA Amery
Sep 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·T PollareH Lithell
Feb 1, 1990·Metabolism: Clinical and Experimental·T PollareC Berne
Jan 1, 1987·Journal of Cardiovascular Pharmacology·V J Dzau, F M Sacks
Apr 29, 1989·BMJ : British Medical Journal·E T SkarforsH Aberg
Jun 5, 1989·The American Journal of Cardiology·M A LambethM B Affrime
Sep 1, 1985·Journal of Pharmacobio-dynamics·K MatsunagaM Ueda
Oct 1, 1987·European Journal of Clinical Investigation·K W JauchG Dietze
Aug 6, 1987·The New England Journal of Medicine·E FerranniniS Bevilacqua
Sep 1, 1987·Diabetologia·M ModanA Lusky
Mar 1, 1985·The Journal of Clinical Investigation·M ModanZ Fuchs
Jul 1, 1985·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S W MacMahonR B Blacket
Jan 1, 1973·Atherosclerosis·J J Barboriak, H D Friedberg
Dec 1, 1984·Diabetes·K ScheideggerE Danforth
Apr 17, 1982·British Medical Journal·J L DayC N Simpson
Apr 1, 1982·Cardiovascular Research·R S Smith, D J Warren
Dec 1, 1984·British Medical Journal·C BengtssonJ A Sigurdsson
Jun 1, 1981·Metabolism: Clinical and Experimental·I H Fox
Dec 10, 1981·The New England Journal of Medicine·P L HooperD R Pathak

❮ Previous
Next ❯

Citations

Jun 6, 2007·Current Diabetes Reports·Pantelis A SarafidisGeorge L Bakris
Sep 12, 2000·Current Hypertension Reports·R D Brook
Dec 4, 2003·Pharmacology & Therapeutics·Noboru Toda
May 21, 2009·Journal of Cardiovascular Pharmacology·George Bakris
Feb 6, 2008·Diabetes, Obesity & Metabolism·D P MacfarlaneM Fisher
Jul 31, 2003·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shinji YagiShigehiro Katayama
Jul 17, 2008·Vascular Health and Risk Management·Panagiotis C Stafylas, Pantelis A Sarafidis
Jun 5, 2012·Vascular Health and Risk Management·Gastone Leonetti, Colin G Egan
Jun 12, 2010·Vascular Health and Risk Management·Janet B McGill
Aug 18, 2006·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Britt KveiborgChristian Torp-Pedersen
Aug 9, 2002·European Journal of Heart Failure·Jens RefsgaardOle Gøtzsche
Aug 26, 2014·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·A H MulderC J Tack
Mar 8, 2006·The Canadian Journal of Cardiology·David F Blackburn, Thomas W Wilson
Aug 4, 2009·Mayo Clinic Proceedings·Marc Klapholz
Nov 9, 2015·Autonomic Neuroscience : Basic & Clinical·Ana Barbara Alves-WagnerUbiratan Fabres Machado
May 17, 2006·International Journal of Clinical Practice·A F SanjulianiE A Francischetti
Apr 24, 2013·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Ayako HakuchoTatsuya Fujimiya
Oct 1, 1996·Metabolism: Clinical and Experimental·A Haenni, H Lithell
Mar 30, 2016·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Pyung Chun OhEak Kyun Shin
Aug 9, 2005·Current Medical Research and Opinion·David S H Bell
Feb 10, 2006·Current Medical Research and Opinion·David S H BellMichael B Fowler
Jan 14, 2004·Critical Care Nursing Clinics of North America·Pamela T RudisillSara Paul
May 12, 2006·The Journal of Clinical Hypertension·Panteleimon A Sarafidis, George L Bakris
Jan 14, 2010·Current Medical Research and Opinion·Vivian A Fonseca
Dec 8, 2006·Expert Opinion on Pharmacotherapy·Gregg C Fonarow
Dec 20, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Pedro GonçalvesFátima Martel
Jul 17, 2010·The American Journal of Medicine·Addison A Taylor, George L Bakris
May 8, 2009·Expert Review of Cardiovascular Therapy·Gregg C Fonarow
Dec 7, 2005·Journal of Hypertension·Risto J Kaaja, Maritta K Pöyhönen-Alho
Nov 18, 2004·Angiology·S S DaskalopoulouM Elisaf
Dec 5, 2006·Journal of Hypertension·Pantelis A Sarafidis, George L Bakris
May 12, 2016·American Journal of Physiology. Endocrinology and Metabolism·R Grace WaltonW Timothy Garvey
Aug 31, 1999·Journal of Hypertension·H M LaivuoriR J Kaaja
Jan 1, 1997·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·H O Lithell
May 13, 1999·Blood Pressure. Supplement·H O Lithell
Jun 20, 2006·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Vicki Oldfield, Katherine A Lyseng-Williamson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.